Literature DB >> 11027639

Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins.

M Bequet-Romero1, O López-Ocejo.   

Abstract

Altered angiogenesis response is observed in patients with cervical cancer. In this study we examined whether Human Papilloma Virus (HPV) positive epithelial cells are able to produce angiogenic modulators. When added to human umbilical vein endothelial cells (HUVEC) the media conditioned by HPV-16 positive cells was able to induce proliferation, whereas a contrary effect was observed for media derived from non-tumorigenic keratinocytes. The analyses of angiogenesis modulator's mRNA levels result in a decrease of the antiangiogenic factors TSP-1 and 2 in HPV-16 positive cells. In contrast the expression of the pro-angiogenic molecules: bFGF, IL-8, TGF-beta, TNFalpha, and VEGF were higher in these cells as compared to control keratinocytes. Furthermore the pattern of VEGF isoforms observed in the cells positive for the viral genome point to a preferential induction of the VEGF(189) isoform. We therefore conclude that cervical cancer cells expressing HPV-16 genome are able to contribute to the pro-angiogenic response that might support tumor growth and invasion of the surrounding tissues. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027639     DOI: 10.1006/bbrc.2000.3628

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.

Authors:  M Branca; C Giorgi; D Santini; L Di Bonito; M Ciotti; A Benedetto; P Paba; S Costa; D Bonifacio; P Di Bonito; L Accardi; C Favalli; K Syrjänen
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines.

Authors:  D Zagury; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Transforming activity of a novel mutant of HPV16 E6E7 fusion gene.

Authors:  Qiang Xie; Zhi-Xiang Zhou; Ze-Lin Li; Yi Zeng
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

Review 4.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

5.  Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancer.

Authors:  Carolyn Y Fang; Brian L Egleston; John A Ridge; Miriam N Lango; Dana H Bovbjerg; Jamie L Studts; Barbara A Burtness; Margret B Einarson; Andres J P Klein-Szanto
Journal:  Head Neck       Date:  2013-10-26       Impact factor: 3.147

Review 6.  Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Zhaojun Shen; Xiaoli Hu; Luzhe Sun; Xueqiong Zhu
Journal:  Tumour Biol       Date:  2016-03-24

7.  Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration.

Authors:  Joanna Walker; Lucy Clare Smiley; David Ingram; Ann Roman
Journal:  Virology       Date:  2010-12-14       Impact factor: 3.616

Review 8.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

9.  Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.

Authors:  Mitsuhiro Nakamura; Jason M Bodily; Melanie Beglin; Satoru Kyo; Masaki Inoue; Laimonis A Laimins
Journal:  Virology       Date:  2009-03-24       Impact factor: 3.616

10.  HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis.

Authors:  Devan Prabhavathy; Bandaru Niranjana Prabhakar; Devarajan Karunagaran
Journal:  Mol Cell Biochem       Date:  2014-05-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.